(0.27%) 5 145.50 points
(0.15%) 38 500 points
(0.41%) 17 918 points
(-0.12%) $83.75
(0.00%) $1.923
(0.10%) $2 349.50
(0.21%) $27.59
(1.99%) $940.45
(-0.15%) $0.933
(-0.30%) $10.99
(-0.31%) $0.798
(1.30%) $93.07
Quarter results today
(bmo 2024-04-29)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European imported drugs and medical products; and manufactures and distributes its generic drugs...
Stats | |
---|---|
本日の出来高 | 1 786.00 |
平均出来高 | 4 092.00 |
時価総額 | 111.50M |
EPS | €0 ( 2024-04-09 ) |
Last Dividend | €1.200 ( 2023-07-19 ) |
Next Dividend | €0 ( N/A ) |
P/E | 11.57 |
ATR14 | €0.511 (2.41%) |
ボリューム 相関
HAEMATO AG 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
HAEMATO AG 相関 - 通貨/商品
HAEMATO AG 財務諸表
Annual | 2022 |
収益: | €248.14M |
総利益: | €15.30M (6.17 %) |
EPS: | €1.570 |
FY | 2022 |
収益: | €248.14M |
総利益: | €15.30M (6.17 %) |
EPS: | €1.570 |
FY | 2021 |
収益: | €285.04M |
総利益: | €30.73M (10.78 %) |
EPS: | €2.74 |
FY | 2020 |
収益: | €238.33M |
総利益: | €17.69M (7.42 %) |
EPS: | €-2.02 |
Financial Reports:
No articles found.
HAEMATO AG Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
€1.100 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€1.200 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | €2.50 | 2011-08-26 |
Last Dividend | €1.200 | 2023-07-19 |
Next Dividend | €0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 11 | -- |
Total Paid Out | €26.30 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.59 | -- |
Div. Sustainability Score | 9.35 | |
Div.Growth Potential Score | 3.85 | |
Div. Directional Score | 6.60 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
RWE.DE | Ex Dividend Junior | 2023-05-05 | Annually | 0 | 0.00% | |
CAR.DE | Ex Dividend Knight | 2023-06-06 | Annually | 0 | 0.00% | |
KEL.DE | Ex Dividend Knight | 2023-08-31 | Quarterly | 0 | 0.00% | |
TIMA.DE | Ex Dividend Junior | 2023-05-10 | Annually | 0 | 0.00% | |
DMP.DE | Ex Dividend Knight | 2023-06-15 | Annually | 0 | 0.00% | |
MTE.DE | Ex Dividend Junior | 2023-07-07 | Quarterly | 0 | 0.00% | |
68V.DE | Ex Dividend Knight | 2023-08-07 | Quarterly | 0 | 0.00% | |
WAF.DE | Ex Dividend Junior | 2023-05-08 | Annually | 0 | 0.00% | |
FIE.DE | Ex Dividend Junior | 2023-07-14 | Annually | 0 | 0.00% | |
PAH3.DE | Ex Dividend Knight | 2023-07-03 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0368 | 1.500 | 9.26 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0524 | 1.200 | 8.25 | 9.90 | [0 - 0.3] |
returnOnEquityTTM | 0.0648 | 1.500 | -0.391 | -0.587 | [0.1 - 1] |
payoutRatioTTM | 0.598 | -1.000 | 4.02 | -4.02 | [0 - 1] |
currentRatioTTM | 2.46 | 0.800 | 2.68 | 2.14 | [1 - 3] |
quickRatioTTM | 1.574 | 0.800 | 5.45 | 4.36 | [0.8 - 2.5] |
cashRatioTTM | 0.444 | 1.500 | 8.64 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0169 | -1.500 | 9.72 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 15.84 | 1.000 | 5.24 | 5.24 | [3 - 30] |
operatingCashFlowPerShareTTM | 2.22 | 2.00 | 9.26 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 2.01 | 2.00 | 8.99 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0207 | -1.500 | 9.92 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.0552 | 1.000 | -2.41 | -2.41 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0351 | 1.000 | -1.297 | -1.297 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 3.73 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 1.422 | 0.800 | 3.86 | 3.08 | [0.5 - 2] |
Total Score | 9.35 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 11.60 | 1.000 | 8.93 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0648 | 2.50 | -0.251 | -0.587 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 2.01 | 2.00 | 9.33 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 5.61 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 2.22 | 2.00 | 9.26 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.598 | 1.500 | 4.02 | -4.02 | [0 - 1] |
pegRatioTTM | 0.0521 | 1.500 | -2.99 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0443 | 1.000 | -1.393 | 0 | [0.1 - 0.5] |
Total Score | 3.85 |
HAEMATO AG
HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European imported drugs and medical products; and manufactures and distributes its generic drugs. It provides pharmaceuticals in the areas of oncology, HIV, rheumatism, neurology, and cardiovascular diseases; and products for aesthetic medicine, as well as cosmetic products. The company also develops and markets medical devices and medical technology products for aesthetic surgery and cosmetic dermatology. It serves wholesalers and pharmacies, as well as doctors, clinics, and medical laboratories. HAEMATO AG was founded in 1993 and is based in Schönefeld, Germany.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。